Efficiency of the use of the drug phlebodia in pregnant women with increased veins of hemoroidal nodes (hemorrhoids)

Abstract

Purpose of the study. To evaluate the results of the effectiveness of the use of the drug Phlebodia in pregnant women with hemorrhoids.

Object and methods of research. We examined 37 patients who were diagnosed with acute and chronic hemorrhoids, who were in the department of pathology of pregnant women No. 1 of the State Research Institute of AH and P for the period 2000-2021. These patients were consulted by a proctologist. After the discharge of pregnant women from the pathology department, further observation was introduced by a proctologist. Inclusion criteria - the presence of subjective and objective signs of the disease in pregnant women. Treatment with Phlebodia 600 was carried out according to a certain scheme: first, 4 days, 1 tablet 3 times a day with meals, and then 1 tablet 2 times a day.

Results of the study and their discussion. The leading symptom of hemorrhoids in pregnant women was pain, which occurred in 81.0%, discomfort (itching) was observed in 43.2%, bleeding from the anus in 32.4%, respectively. When prescribing the drug Flebodia, we achieved positive results. In the course of our study, it was possible in 91.8% of pregnant women with an established diagnosis of hemorrhoids to achieve such positive results as the elimination of such symptoms as the cessation of bleeding, perianal edema, pain and itching.

Conclusion. In pregnant women who used the drug Flebodia 600, there was a positive hemodynamics in the clinical symptoms of hemorrhoids.